Idexx expands snap platform with leish 4dx test to support veterinarians globally in diagnosing vector-borne diseases

The rapid diagnostic test provides a comprehensive solution for detecting canine leishmaniosis that impacts one in 10 dogs in endemic regions westbrook, maine , nov. 8, 2023 /prnewswire/ -- idexx laboratories, inc. (nasdaq: idxx), a global leader in pet healthcare innovation, announced the upcoming launch of the snap® leish 4dx® test, a comprehensive screening test for vector-borne diseases, including canine leishmaniosis. the snap leish 4dx test uses the trusted snap 4dx plus testing platform, which detects lyme disease, heartworm disease, ehrlichiosis, and anaplasmosis.
IDXX Ratings Summary
IDXX Quant Ranking